Gunawardena, Harshi
Leontini, Rose
Nair, Sham
Cross, Shane
Hickie, Ian
Article History
Received: 29 October 2022
Accepted: 27 December 2023
First Online: 23 January 2024
Declarations
:
: This study received ethics approval from the University of Sydney Human Research Ethics Committee (HREC) (Ref No: 2018/045) and the NSW State Education Research Applications Process (SERAP 2017612). All methods were carried out in accordance with relevant guidelines and regulations provided by the University of Sydney’s HREC and by SERAP. Written and verbal informed consent was received from all participants upon their recruitment for this study.
: N/A.
: Professor Ian Hickie is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. Professor Hickie has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He is the Chief Scientific Advisor to, and a 5% equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30 M Australian Government-funded Project Synergy (2017-20) and to lead transformation of mental health services internationally through the use of innovative technologies. There are no relevant disclosures for other authors.